Evidence mapPaperPMID 37375585Full record

ReviewNutrients2023

Evidence of Immunomodulatory Food-Protein Derived Peptides in Human Nutritional Interventions: Review on the Outcomes and Potential Limitations.

Fernando Rivero-Pino, Álvaro Villanueva, Sergio Montserrat-de-la-Paz, Susana Sanchez-Fidalgo, Maria C Millán-Linares

Open access · goldAbstract readReview
In one paragraph

Review in Nutrients, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Functional Food Ingredients Enhancing Immune Health.International journal of molecular sciences · 2025
    Review
  3. Article
  4. Sacha Inchi (Foods (Basel, Switzerland) · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Fernando Rivero-PinoDepartment of Medical Biochemistry, Molecular Biology, and Immunology, School of Medicine, University of Seville, Av. Sanchez Pizjuan s/n, 41009 Seville, Spain.ORCID 0000-0003-1326-7452
Álvaro VillanuevaDepartment of Food & Health, Instituto de la Grasa (IG-CSIC), Campus Universitario Pablo de Olavide, Ctra. Utrera Km. 1, 41013 Seville, Spain.ORCID 0000-0001-8180-688X
Sergio Montserrat-de-la-PazDepartment of Medical Biochemistry, Molecular Biology, and Immunology, School of Medicine, University of Seville, Av. Sanchez Pizjuan s/n, 41009 Seville, Spain.ORCID 0000-0001-5400-3192
Susana Sanchez-FidalgoDepartment of Preventive Medicine and Public Health, School of Medicine, University of Seville, Av. Sanchez Pizjuan s/n, 41009 Seville, Spain.ORCID 0000-0002-3630-7122
Maria C Millán-LinaresDepartment of Medical Biochemistry, Molecular Biology, and Immunology, School of Medicine, University of Seville, Av. Sanchez Pizjuan s/n, 41009 Seville, Spain.ORCID 0000-0002-5661-8366
Universidad de Sevilla · ESInstituto de la Grasa · ES

Funding

Andalusian Plan for Research, Development and Innovation (PAIDI) 2020 P20_00661European Regional Development Fund (ERDF) US-1381492
6 · The paper itself

Abstract

The immune system is somehow related to all the metabolic pathways, in a bidirectional way, and the nutritional interventions affecting these pathways might have a relevant impact on the inflammatory status of the individuals. Food-derived peptides have been demonstrated to exert several bioactivities by in vitro or animal studies. Their potential to be used as functional food is promising, considering the simplicity of their production and the high value of the products obtained. However, the number of human studies performed until now to demonstrate effects in vivo is still scarce. Several factors must be taken into consideration to carry out a high-quality human study to demonstrate immunomodulatory-promoting properties of a test item. This review aims to summarize the recent human studies published in which the purpose was to demonstrate bioactivity of protein hydrolysates, highlighting the main results and the limitations that can restrict the relevance of the studies. Results collected are promising, although in some studies, physiological changes could not be observed. When responses were observed, they sometimes did not refer to relevant parameters and the immunomodulatory properties could not be clearly established with the current evidence. Well-designed clinical trials are needed in order to evaluate the role of protein hydrolysates in immunonutrition.

Indexed as

PeptidesProtein HydrolysatesAnimalsFunctional FoodHumansPeptidesProtein Hydrolysatesantidiabeticantioxidantclinical trialcytokinesimmune systeminflammationprotein hydrolysatevalidation

Identifiers

PMID37375585
PMCPMC10301473
OpenAlexW4379927652

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.